Andere Sprachen Quanterix Corporation

Aktien

A2H9FB

US74766Q1013

QTRX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 14.06.2024			% 5 Tage	% 1. Jan.
13,32 ^USD	-8,26 %		-21,65 %	-51,28 %

12.06.	Transcript : Quanterix Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 02:40 PM
08.05.	Transcript : Quanterix Corporation, Q1 2024 Earnings Call, May 08, 2024

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference	05.06.
Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024	22.05.
Quanterix Corporation Announces Resignation of Brian J. Blaser from its Board of Directors	07.05.
Earnings Flash (QTRX) QUANTERIX CORPORATION Posts Q1 Revenue $32.1M, vs. Street Est of $31.5M	07.05.
Quanterix Releases Financial Results for the First Quarter of 2024	07.05.
Quanterix Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	07.05.
Quanterix Corporation Provides Earnings Guidance for the Full-Year 2024	07.05.
Quanterix To Report First Quarter 2024 Financial Results	29.04.
Quanterix Corporation Announces Laurie Olson, Director Will Not Stand for Re-Election	12.04.
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure	21.03.
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease	04.03.
Quanterix Corporation Receives Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer?s Disease	04.03.
Quanterix Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
Quanterix Corporation Provides Earnings Guidance for the Year 2024	29.02.
Quanterix Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29.02.
Earnings Flash (QTRX) QUANTERIX CORPORATION Reports Q4 Revenue $31.5M, vs. Street Est of $29.8M	29.02.
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023	29.02.
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance	27.02.
Quanterix Corporation Reaffirms Earnings Guidance for the Year 2023	27.02.
Quanterix to Present at Cowen's 44th Annual Health Care Conference	26.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Quanterix Corporation

Aktien

A2H9FB

US74766Q1013

QTRX

Andere Sprachen

Filter